These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 7482229)

  • 1. Multiple sclerosis: a unique immunopathological syndrome of the central nervous system.
    Hunter SF; Rodriguez M
    Springer Semin Immunopathol; 1995; 17(1):89-105. PubMed ID: 7482229
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphocyte phenotypes in the multiple sclerosis lesion--what do they mean?
    Zweiman B; Lisak RP
    Ann Neurol; 1986 Jun; 19(6):588-9. PubMed ID: 2942098
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroinflammation: A common denominator for stroke, multiple sclerosis and Alzheimer's disease.
    Vries HE; Schwaninger M
    Biochim Biophys Acta; 2016 Mar; 1862(3):297-8. PubMed ID: 26748252
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dendritic cells and their role in inflammation in the central nervous system].
    Pashchenkov MV; Pinegin BV; Link Kh; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; (Spec No 2):39-46. PubMed ID: 12938633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cells and microglia as drivers of multiple sclerosis pathology.
    Friese MA; Fugger L
    Brain; 2007 Nov; 130(Pt 11):2755-7. PubMed ID: 17956912
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased immune reactivity to central nervous system-derived naturally presented peptides in patients with active multiple sclerosis.
    Riedhammer C; Halbritter D; Weissert R
    J Allergy Clin Immunol; 2017 Feb; 139(2):694-696.e7. PubMed ID: 27639936
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of chemokines in the pathogenesis of multiple sclerosis.
    Woodroofe N; Cross AK; Harkness K; Simpson JE
    Adv Exp Med Biol; 1999; 468():135-50. PubMed ID: 10635025
    [No Abstract]   [Full Text] [Related]  

  • 8. The CNS as a therapeutic target in multiple sclerosis.
    Antel JP
    Curr Neurol Neurosci Rep; 2008 Nov; 8(6):445-7. PubMed ID: 18957179
    [No Abstract]   [Full Text] [Related]  

  • 9. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis.
    Meinl E; Krumbholz M; Derfuss T; Junker A; Hohlfeld R
    J Neurol Sci; 2008 Nov; 274(1-2):42-4. PubMed ID: 18715571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathological Techniques to Investigate Central Nervous System Sections in Multiple Sclerosis.
    Bauer J; Lassmann H
    Methods Mol Biol; 2016; 1304():211-29. PubMed ID: 25520281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis: immunopathologic mechanisms in the progression and resolution of inflammatory demyelination.
    Raine CS
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():37-54. PubMed ID: 1691521
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression and cellular localization of major histocompatibility complex antigens in active multiple sclerosis lesions.
    Hayashi T; Burks JS; Hauser SL
    Ann N Y Acad Sci; 1988; 540():301-5. PubMed ID: 3061338
    [No Abstract]   [Full Text] [Related]  

  • 13. Emerging Role for Methylation in Multiple Sclerosis: Beyond DNA.
    Webb LM; Guerau-de-Arellano M
    Trends Mol Med; 2017 Jun; 23(6):546-562. PubMed ID: 28478950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The virtues and vices of harnessing HSV vectors for CNS autoimmunity modulation.
    Hukkanen V; Nygårdas M
    Immunotherapy; 2013 Sep; 5(9):911-3. PubMed ID: 23998724
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple sclerosis: an infectious syndrome involving Chlamydophila pneumoniae.
    Stratton CW; Wheldon DB
    Trends Microbiol; 2006 Nov; 14(11):474-9. PubMed ID: 16996738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the damaging versus regenerative roles of CNS macrophages: implications for the use of immunomodulatory therapeutics.
    Miron VE
    Regen Med; 2013 Nov; 8(6):673-6. PubMed ID: 24147520
    [No Abstract]   [Full Text] [Related]  

  • 17. Is natalizumab overshooting its rebound?
    Fox RJ; Kappos L
    Neurology; 2008 Mar; 70(13 Pt 2):1073-4. PubMed ID: 18362270
    [No Abstract]   [Full Text] [Related]  

  • 18. The possible role of prolactin in the immunopathogenesis of multiple sclerosis.
    Draca S; Lević Z
    Med Hypotheses; 1996 Aug; 47(2):89-92. PubMed ID: 8869921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, radiological, immunological and pathological findings in inflammatory CNS demyelination--possible markers for an antibody-mediated process.
    Brück W; Neubert K; Berger T; Weber JR
    Mult Scler; 2001 Jun; 7(3):173-7. PubMed ID: 11475441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The best basic science paper in multiple sclerosis in 2014: important role for the choroid plexus in the central nervous system entry of leukocytes.
    Kooij G; de Vries HE
    Mult Scler; 2015 Apr; 21(4):372-3. PubMed ID: 25716882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.